81049-21-0

Upstream product

• 14062-30-7 ethyl 2-(3-bromophenyl)acetate 
• 69574-21-6 ethyl 2-(3-isopropylphenyl)acetate 
• 134365-18-7 2-(3-Isopropyl-phenyl)-1-morpholin-4-yl-ethanethione 

Downstream Products

• 134365-20-1 (4R,5R)-7-(3-Isopropylphenyl)-5-nitromethyl-4,1-heptanecarbolactone 
• 134365-15-4 (4R,5S)-7-(3-Isopropylphenyl)-5-nitromethyl-4,1-heptanecarbolactone 
• 134454-01-6 Methyl (1R,2R)-2-<2-(3-Isopropylphenyl)ethyl>-1-methyl-3-oxo-1-cyclohexanecarboxylate 
• 134454-00-5 Methyl (1R,2S)-2-<2-(3-Isopropylphenyl)ethyl>-1-methyl-3-oxo-1-cyclohexanecarboxylate 
• 134365-19-8 (R)-2-(3-Hydroxy-propyl)-5-(3-isopropyl-phenyl)-2-methyl-3-nitromethyl-pentanoic acid methyl ester 
• 134365-17-6 Methyl (1R,2S,3R)-1,3-Dimethyl-1-hydroxy-2<2-(3-isopropylphenyl)-ethyl>cyclohexanecarboxylate 
• 72646-50-5 2-(3-Isopropylphenyl)ethyl Bromide 
• 57119-17-2 9,10-seco-abieta-8,11,13-trien-18,10α-olide 
• 68480-22-8 3-isopropyl-phenethyl alcohol 

Relevant academic research and scientific papers

Optimization of potent and selective quinazolinediones: Inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity

A quinazolinedione-derived screening hit 2 was discovered with cellular antiviral activity against respiratory syncytial virus (CPE EC50 = 2.1 μM), moderate efficacy in reducing viral progeny (4.2 log at 10 μM), and marginal cytotoxic liability